The company is heavily reliant on a cancer drug that could be targeted by a program intended to lower drug prices.
Author: Rebecca Robbins
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}Merck Sues Over Medicare Drug-Price Negotiation Law